Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2025 09:40 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) projects €8.5 Billion revenue from its distribution agreements for Nigeria, Ukraine, UAE, Iraq, Syria, and Jordan.
April 11, 2025 11:35 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Latest Developments

Nika Pharmaceuticals, Inc. (OTCQB: NIKA)'s report on the therapeutic effect of ITV-1 on AIDS, Cancer, Hepatitis volunteers and Nika Europe factory progress
July 18, 2024 11:35 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria

Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.
December 11, 2023 17:16 ET | Source: Sagaliam Acquisition Corp

SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ DELISTING LETTER

New York, NY, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, SAGAR”) (the “Company”) received a delisting notification letter (“Notice”) from the Listing...